Oncologic therapies
ثبت نشده
چکیده
The amount of new biomedical literature that the world gets bombarded with these days may sometimes seem overwhelming. Yet, research results need to be reported in peer-reviewed journals and researchers need to publish regularly. Journal publication, whether on paper or on-line, is here to stay. However, it is not just the formal end-point of a research project; it is an integral part of research that documents new information gleaned from an investigation, and in so doing inspires more research, in an endless search for truth. Peer review of manuscripts and grant proposals, journalology, metaanalysis, evidence-based medicine, and worldwide database access are elements of this search for the truth.
منابع مشابه
Collaborative models for increasing efficiency of early drug assessment
Methods The Austrian Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA) implemented an EAAS specifically for oncologic drugs in 2009 [2]. Due to rising costs for cancer therapies, oncologic drugs are of importance throughout Europe and are therefore assessed concurrently by health technology assessment (HTA) agencies leading to considerable redundancies. Experiences of the LB...
متن کاملThe gastrointestinal complications of oncologic therapy.
A spectrum of oncologic treatments including chemotherapy, radiotherapy, and molecular targeted therapies is available to combat cancer. These treatments are associated with adverse effects in several organ systems including the gastrointestinal (GI) tract. The immunocompromised state induced by oncologic therapy is also an important contributing factor underlying GI complications. This review ...
متن کاملNovel Systemic Therapies for Advanced Gastric Cancer
Gastric cancer (GC) is the second leading cause of cancer mortality and the fourth most commonly diagnosed malignant diseases. While continued efforts have been focused on GC treatment, the introduction of trastuzumab marked the beginning of a new era of target-specific treatments. Considering the diversity of mutations in GC, satisfactory results obtained from various target-specific therapies...
متن کامل[Causes and impact of hyponutrition and cachexia in the oncologic patient].
The maximal expression of hyponutrition in cancer is tumoral cachexia, which will direct or indirectly account for mortality in one third of cancer patients. Causes of hyponutrition in cancer are related with the tumor, the patient, or therapies, and summarily we may differentiate four main mechanisms by which hyponutrition may occur in cancer patients: Poor energy and nutrients intake; Impairm...
متن کاملChest CT for suspected pulmonary complications of oncologic therapies: how I review and report.
In cancer patient during or following oncologic therapies with respiratory symptoms and pulmonary pathology at chest CT the differential diagnosis includes infection, therapy-induced disease and tumour progression.Although CT morphology may be typical or even pathognomonic in some conditions the diagnosis is usually made by a synopsis of imaging, clinical and laboratory features.Close communica...
متن کامل